🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Lukas Lusuardi

University of Salzburg

ORCID: 0000-0002-5284-7276

Also affiliated with Paracelsus Medical University, Fachhochschule Salzburg, Universitätskliniken Salzburg, Unfallkrankenhaus Salzburg, Salzburger Landeskliniken

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

N/A
0Author DataRank · unranked

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 1 paper. Top paper: “Current Systemic Treatment Options in Metastatic Urothelial Carcinoma after Progression on Checkpoint Inhibition Therapy—A Systemic Review Combined with Single-Group Meta-Analysis of Three Studies Testing Enfortumab Vedotin”.

Current Systemic Treatment Options in Metastatic Urothelial Carcinoma after Progression on Checkpoint Inhibition Therapy—A Systemic Review Combined with Single-Group Meta-Analysis of Three Studies Testing Enfortumab Vedotin

Cancers(2021)10.3390/cancers13133206
N/A
0.360DataRank · unranked
10 citations

Peter Törzsök, David Oswald, Lukas Lusuardi, Susanne Deininger